Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of ST14 mRNA | increases expression | 16788091
|
D003520 |
Cyclophosphamide |
[Doxorubicin co-treated with Cyclophosphamide] affects the expression of ST14 mRNA | affects cotreatment|affects expression | 16322899
|
D004317 |
Doxorubicin |
[Doxorubicin co-treated with Cyclophosphamide] affects the expression of ST14 mRNA | affects cotreatment|affects expression | 16322899
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of ST14 mRNA | increases expression | 17942748
|
D008743 |
Methyl Parathion |
Methyl Parathion affects the expression of ST14 mRNA | affects expression | 19784758
|
D008743 |
Methyl Parathion |
Methyl Parathion results in decreased expression of ST14 mRNA | decreases expression | 19784758
|
D008743 |
Methyl Parathion |
Methyl Parathion results in increased expression of ST14 mRNA | increases expression | 19784758
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ST14 mRNA | affects binding|increases activity|increases expression | 19710929
|
D012643 |
Selenium |
Selenium results in increased expression of ST14 mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.38 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.42 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.58 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.58 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.88 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.87 | 21441931 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
11.39 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
11.39 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.82 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.43 | 19483382 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.14 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.07 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.56 | 15093573 16978400 17020986 12006526 18234424 11325840 15136595 18323546 17388661 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.56 | 19526202 16935488 18234424 15634643 15692762 15994142 17983394 15136595 16826403 16322301 17369602 15939500 15668708 16264153 11325840 16096432 16115903 15993339 18695136 18628466 18382427 17426702 16595493 15567936 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.25 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
3.55 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.55 | 16234567 18059187 16023760 17876044 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.28 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
7.24 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
7.24 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.70 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.70 | 16731534 16242529 18627295 17329180 16269455 17007740 16651473 17974986 15811867 16278810 16109756 16612575 17351982 17519947 15505089 17308081 16364871 16455267 15792986 17924179 17131338 17928571 17382496 16952015 15476868 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.02 | 16243910 17334414 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.42 | 15861022 17681005 17333356 11677210 17110522 16105132 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.42 | 19176532 |
MESH:D003092 |
Colitis |
|
Selenium |
4.14 | 17936198 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.43 | 16413132 15643279 16614059 18433785 10498854 12913760 15276878 10700343 18372110 17979934 12388444 12161096 16989017 18483878 18093676 18295254 17010015 16651033 18710439 11948286 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.53 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.30 | 11751995 15331540 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.29 | 18772604 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
4.33 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
4.33 | 15131321 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.87 | 18602426 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.76 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.52 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.62 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.60 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.57 | 11006010 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
8.50 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.50 | 20131406 19236843 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.98 | 19069698 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.52 | 17150277 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.91 | 11389073 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.39 | 16376943 11014644 15172196 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.70 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.67 | 18006777 16879835 16244372 12587719 17875725 16707910 16495754 16244371 14766674 16144979 18674790 16330681 17888722 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
12.73 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
12.73 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
12.73 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.18 | 15692506 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.65 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.98 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.35 | 16221962 19176532 19772884 18467677 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
8.54 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
8.54 | 15147373 17606976 18501091 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.45 | 20558911 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.17 | 16945680 16569931 |
MESH:C536273 |
Ichthyosis with hypotrichosis, autosomal recessive |
marker/mechanism |
|
| |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.77 | 16076520 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.77 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
7.46 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.46 | 17937319 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.64 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.80 | 16306350 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.20 | 15699352 16775033 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
10.94 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
10.94 | 16518626 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.61 | 10602166 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.60 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.59 | 17802794 18172266 17296974 17008537 18587576 17658394 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.29 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.36 | 10052129 11830472 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.54 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.54 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.90 | 16377806 20007298 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.17 | 16842330 17085340 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.15 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
8.53 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
8.53 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.90 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
9.78 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
9.78 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.93 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.75 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.75 | 15318939 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.32 | 16827129 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
5.16 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.60 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.60 | 15107826 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.78 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.19 | 17415656 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.86 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
6.04 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.04 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.16 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.04 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
5.58 | 18854779 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.58 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.13 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.25 | 16889571 15640375 |
MESH:D056770 |
Netherton Syndrome |
marker/mechanism |
|
| 20657595 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
7.63 | 16115947 8761367 15176712 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.63 | 15555623 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.28 | 8761367 12837982 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Methyl Parathion |
5.02 | 19784758 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.63 | 8291058 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
5.11 | 16517039 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.34 | 15930896 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.85 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
3.26 | 11332152 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.99 | 11578682 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.60 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.33 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.60 | 17638057 |
MESH:D011041 |
Poisoning |
|
Methyl Parathion |
5.34 | 17603234 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.94 | 21297632 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17013881 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.57 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.57 | 18437689 15897917 16729912 16868541 16888761 15749863 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.71 | 15861022 16919318 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.37 | 16636934 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.58 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.50 | 19058328 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.25 | 16767912 18313854 17203757 17710206 15625365 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.57 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.19 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
5.13 | 16636934 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.06 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.93 | 16767912 15625365 17203757 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.38 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.91 | 16517039 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.45 | 12837982 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.92 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.40 | 15669648 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.58 | 16010429 17909728 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
5.81 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.81 | 17653716 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.63 | 14692618 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.82 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.58 | 17334414 16364871 17638931 17678736 |